Search Results - "TRIOZZI, P. L"
-
1
Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands
Published in Gene therapy (01-01-2006)“…The potential of adeno-associated virus (AAV)-based vectors in human gene therapy is being explored for several diseases. Although sustained transgene…”
Get full text
Journal Article -
2
Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells
Published in Gene therapy (01-09-2002)“…A promising approach to immunotherapy involves the loading of dendritic cells (DCs) with genetic material to facilitate sustained expression of a relevant…”
Get full text
Journal Article -
3
Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine
Published in Cancer research (Chicago, Ill.) (15-07-2000)“…Synthetic peptide vaccines targeting B-cell epitopes of the extracellular domain of the HER-2 oncoprotein were evaluated for their capacity to elicit…”
Get full text
Journal Article -
4
Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll-like receptor agonists
Published in Cancer gene therapy (01-12-2011)“…Carcinoembryonic antigen (CEA) is a cancer vaccines’ target. Several features of recombinant adeno-associated virus (rAAV) are attractive for vaccine…”
Get full text
Journal Article -
5
B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity
Published in Gene therapy (01-06-2000)“…Enhanced immunogenicity has been reported following transfection of a variety of immunogenic tumors with the B7.1 co-stimulatory molecule. The purpose of the…”
Get full text
Journal Article -
6
Effects of a beta-human chorionic gonadotropin subunit immunogen administered in aqueous solution with a novel nonionic block copolymer adjuvant in patients with advanced cancer
Published in Clinical cancer research (01-12-1997)“…The clinical and immunological effects of a vaccine consisting of CTP37, a synthetic peptide corresponding to the COOH-terminal peptide (CTP) of beta-human…”
Get full text
Journal Article -
7
Phenotypic and functional differences between human dendritic cells derived in vitro from hematopoietic progenitors and from monocytes/macrophages
Published in Journal of leukocyte biology (01-05-1997)“…We compared dendritic cells (DC) derived from CD34+ hematopoietic progenitor cells with tumor necrosis factor α and granulocyte‐macrophage colony‐stimulating…”
Get full text
Journal Article -
8
Endoresection for choroidal melanoma: palliative or curative intent?
Published in British journal of ophthalmology (01-08-2008)Get more information
Journal Article -
9
Antitumor and accessory immune activities of peripheral blood stem cells mobilized with granulocyte-macrophage colony-stimulating factor
Published in Bone marrow transplantation (Basingstoke) (01-07-1996)“…The characteristics of PBSC mobilized with GM-CSF, which has been shown to augment monocyte/macrophage (Mo/Mx) antitumor and accessory activities, were…”
Get more information
Journal Article -
10
HIV type 1-reactive chemokine-producing CD8+ and CD4+ cells expanded from infected lymph nodes
Published in AIDS research and human retroviruses (20-05-1998)“…The chemokines RANTES, MIP-1alpha, and MIP-1beta have been identified as HIV-1-suppressive factors produced by CD8+ T cells. We examined the possibility that…”
Get more information
Journal Article -
11
Genetically Targeted Adenovirus Vector Directed to CD40-Expressing Cells
Published in Journal of Virology (01-11-2003)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
12
Modulation of CD4 cell cytokine production by colon cancer-associated mucin
Published in Cancer Immunology, Immunotherapy (01-12-1999)“…Mucins have been implicated in tumor-associated immunosuppression. The possibility that colon cancer mucin (CCM) may modulate T-helper 1 (TH1) activity was…”
Get full text
Journal Article -
13
Phase I trial of escalating doses of interleukin-1 beta in combination with a fixed dose of interleukin-2
Published in Journal of clinical oncology (01-02-1995)“…Interleukin-1 (IL-1) and IL-2 have synergistic antitumor and myelostimulatory activities. We investigated the clinical and biologic effects of IL-1/IL-2…”
Get more information
Journal Article -
14
Intratumoral injection of dendritic cells derived in vitro in patients with metastatic cancer
Published in Cancer (15-12-2000)“…BACKGROUND Dendritic cells (DCs) are potent initiators of immune responses, and the infiltration of DCs into tumors may confer an improved prognosis. Whether…”
Get full text
Journal Article -
15
High-dose chemotherapy for breast cancer
Published in Cancer treatment reviews (01-05-1995)Get full text
Journal Article -
16
Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor
Published in Vaccine (26-01-2004)“…KSA (Ep-CAM) is highly expressed by colorectal cancers. The safety and immunologic effects of a vaccine consisting of recombinant baculovirus-derived KSA…”
Get full text
Journal Article -
17
Cellular Immunotherapy of Advanced Human Immunodeficiency Virus Type 1 Infection Using Autologous Lymph Node Lymphocytes: Effects on Chemokine Production
Published in The Journal of infectious diseases (01-01-1999)“…A pilot study was undertaken in patients with human immunodeficiency virus type 1 (HIV-1) infection to examine the effects of infusing autologous lymph node…”
Get full text
Journal Article -
18
Isotretinoin and recombinant interferon alfa-2a therapy of metastatic malignant melanoma
Published in Cancer investigation (1996)“…Twenty-five patients with metastatic malignant melanoma were treated with isotretinoin (13-cis-retinoic acid) orally at 1 mg/kg daily and recombinant…”
Get more information
Journal Article -
19
Optimum management of nausea and vomiting in cancer chemotherapy
Published in Drugs (New York, N.Y.) (01-07-1987)“…Nausea and vomiting continue to be critical problems in cancer chemotherapy, although considerable progress has been made toward understanding the…”
Get full text
Journal Article -
20
Identification and activation of tumor-reactive cells for adoptive immunotherapy
Published in Stem cells (Dayton, Ohio) (01-05-1993)“…The use of adoptive immunotherapy to treat cancer has several potential advantages. Although extensive evaluation has been undertaken, issues regarding the…”
Get more information
Journal Article